| | FARS2, LOC126859565 (R148W) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (H159Y) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (nonsense +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (intron variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | not provided | |
| | FARS2, LOC126859565 (A170V) | Single nucleotide variant (missense variant +1 more) | FARS2-related condition | |
| | FARS2, LOC126859565 (H63N) | Single nucleotide variant (missense variant +1 more) | not provided | |
| | FARS2, LOC126859565 (E95G) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (W87C) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (M151I) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (Q60*) | Single nucleotide variant (nonsense +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (L168fs) | Duplication (frameshift variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (L130F) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | LOC126859565, FARS2 (V51L) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (L130R) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (T149S) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (R104H) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (A170T) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (G106V) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (A42V) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (A38E) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (K69R) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (K99R) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | not provided | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | FARS2-related condition +1 more | |
| | | Single nucleotide variant (intron variant) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (intron variant) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (N147K) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (D142N) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | LOC126859565, FARS2 (G75V) | Single nucleotide variant (intron variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (H29R) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (V197M) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (D62Y) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (W87G) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (K99N) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (A31T) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (D142G) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (P136L) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (S49N) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (S137G) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 +1 more | |
| | FARS2, LOC126859565 (L172P) | Single nucleotide variant (missense variant +1 more) | Hereditary spastic paraplegia 77 +1 more | |
| | FARS2, LOC126859565 (S128G) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (R198W) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (R180H) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (R148Q) | Single nucleotide variant (missense variant +1 more) | not provided +1 more | |
| | FARS2, LOC126859565 (Y188H) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (Q44R) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (G103A) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (D142fs) | Deletion (frameshift variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (A10T) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (W32R) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | FARS2, LOC126859565 (D62N) | Single nucleotide variant (missense variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 +1 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | | Single nucleotide variant (synonymous variant +1 more) | Combined oxidative phosphorylation defect type 14 | |
| | LOC126859565, FARS2 (Q100*) | Single nucleotide variant (nonsense +1 more) | Combined oxidative phosphorylation defect type 14 +1 more | |
| | | Single nucleotide variant (missense variant +2 more) | Combined oxidative phosphorylation defect type 14 | |